These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36639375)

  • 1. RBM4 regulates cellular senescence via miR1244/SERPINE1 axis.
    Wang L; Zhang X; Sheng J; Chen L; Zhi L; Zheng Q; Qi Y; Wang L; Zhang J; Zhao J; Wang Y; Liu SX; Sun MZ; Zhang W
    Cell Death Dis; 2023 Jan; 14(1):27. PubMed ID: 36639375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
    Chen L; Zhang W; Chen D; Yang Q; Sun S; Dai Z; Li Z; Liang X; Chen C; Jiao Y; Zhi L; Zhao L; Zhang J; Liu X; Zhao J; Li M; Wang Y; Qi Y
    Signal Transduct Target Ther; 2023 Apr; 8(1):159. PubMed ID: 37080995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
    Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
    Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Long Non-coding RNA LINC00200 Inhibits Gastric Cancer Progression by Regulating miR-143-3p/SERPINE1 Axis.
    He W; Zhang D; Li D; Zhu D; Geng Y; Wang Q; He J; Wu J
    Dig Dis Sci; 2021 Oct; 66(10):3404-3414. PubMed ID: 33141390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear Aurora kinase A switches m
    Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-504 Promoted Gastric Cancer Cell Proliferation and Inhibited Cell Apoptosis by Targeting RBM4.
    Zhang Y; Yong H; Fu J; Gao G; Shi H; Zhou X; Fu M
    J Immunol Res; 2021; 2021():5555950. PubMed ID: 34195294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation.
    Zhang D; Zhang JW; Xu H; Chen X; Gao Y; Jiang HG; Wang Y; Wu H; Yang L; Wang WB; Dai J; Xia L; Peng J; Zhou FX
    Mol Cancer; 2024 Apr; 23(1):70. PubMed ID: 38576002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBM4-MEF2C network constitutes a feed-forward circuit that facilitates the differentiation of brown adipocytes.
    Lin JC
    RNA Biol; 2015; 12(2):208-20. PubMed ID: 25826570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-Binding Motif 4 (RBM4) Suppresses Tumor Growth and Metastasis in Human Gastric Cancer.
    Yong H; Zhao W; Zhou X; Liu Z; Tang Q; Shi H; Cheng R; Zhang X; Qiu Z; Zhu J; Feng Z
    Med Sci Monit; 2019 May; 25():4025-4034. PubMed ID: 31145716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
    Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
    Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis.
    Huangfu N; Zheng W; Xu Z; Wang S; Wang Y; Cheng J; Li Z; Cheng K; Zhang S; Chen X; Zhu J
    Int Immunopharmacol; 2020 Jun; 83():106432. PubMed ID: 32248017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel circular RNA circZNF652/miR-486-5p/SERPINE1 signaling cascade that regulates cancer aggressiveness in glioblastoma (GBM).
    Liu L; Xiao S; Wang Y; Zhu Z; Cao Y; Yang S; Mai R; Zheng Y
    Bioengineered; 2022 Jan; 13(1):1411-1423. PubMed ID: 35258403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
    Liao XH; Wang Y; Zhong B; Zhu SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 617 Targeting SERPINE1 Inhibited the Progression of Oral Squamous Cell Carcinoma.
    Zhao C; Liu Z
    Mol Cell Biol; 2021 May; 41(6):e0056520. PubMed ID: 33820852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome-wide targets of alternative splicing by RBM4 and possible role in cancer.
    Markus MA; Yang YH; Morris BJ
    Genomics; 2016 Apr; 107(4):138-44. PubMed ID: 26898347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
    Guo Y; Li P; Gao L; Zhang J; Yang Z; Bledsoe G; Chang E; Chao L; Chao J
    Aging Cell; 2017 Aug; 16(4):837-846. PubMed ID: 28544111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Prognostic and Immune Infiltration Analysis of RBM4 in Pan-Cancer.
    Ding JJ; Wu J; Bian HL; Zong Y; Lu B; Ni L
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):89. PubMed ID: 38420804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of mm9_circ_013935 alleviates renal inflammation and fibrosis in diabetic nephropathy via the miR-153-3p/NFIC axis.
    Zhang L; Zhang L; Li S; Zhang Q; Luo Y; Zhang C; Huan Q; Zhang C
    Can J Physiol Pharmacol; 2021 Nov; 99(11):1199-1206. PubMed ID: 34197715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
    Chang HL; Lin JC
    Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine1.
    McCann JV; Xiao L; Kim DJ; Khan OF; Kowalski PS; Anderson DG; Pecot CV; Azam SH; Parker JS; Tsai YS; Wolberg AS; Turner SD; Tatsumi K; Mackman N; Dudley AC
    J Clin Invest; 2019 Mar; 129(4):1654-1670. PubMed ID: 30855280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.